An Australian specialty pharmaceutical company focused on the development of new products for the diagnosis and treatment of chronic respiratory and inflammatory/autoimmune diseases.
The best Bull and Bear pitches based on recency and number of recommendations.
If they can get their drugs into the Asian market, they should do well.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about PXSLY.
Recs
dawg99pound
(42.89)
Submitted: 11/27/2006 10:45:19 PM :
Start Price:
$25.00
NASDAQ OTC:PXSLY Score:
-315.41
5 star stock after horrible day
Find the members with the highest scoring picks in PXSLY.
anticitradeshort (27.96) Score: +489.30
The Score Leader is the player with the highest score across all their picks in PXSLY.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| anticitradeshort | 27.96 | 4/20/2009 |
|
NS | $19.50 | -79.73% | +409.57% | +489.30 | 0 Comment | |
| BradAllenton | 32.44 | 2/5/2009 |
|
NS | $10.55 | -62.55% | +418.26% | +480.81 | 0 Comment | |
| truebluefool13 | 94.90 | 9/14/2007 |
|
3W | $48.00 | -91.77% | +206.91% | +298.68 | 0 Comment | |
|
ljwheeler | 56.59 |
|
|
3Y | $46.74 | -91.54% | +194.53% | -286.07 | 0 Comment |
| wEzXz | 24.37 | 7/12/2007 |
|
5Y | $42.50 | -90.70% | +198.02% | -288.72 | 0 Comment | |
| gators1n96 | 45.40 | 6/28/2007 |
|
1Y | $42.48 | -90.70% | +206.22% | -296.92 | 0 Comment | |
| DBlizz66 | 81.90 | 8/1/2007 |
|
3Y | $40.50 | -90.24% | +208.13% | -298.37 | 0 Comment | |
| maggieromeo | < 20 | 8/13/2007 |
|
NS | $42.90 | -90.79% | +209.98% | -300.77 | 0 Comment | |
| BUX28 | < 20 | 11/15/2007 |
|
NS | $57.50 | -93.13% | +208.37% | -301.50 | 0 Comment | |
| djcnz | 62.28 | 8/21/2007 |
|
3Y | $40.28 | -90.19% | +212.81% | -303.00 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
